PLACENTA-DERIVED ADHERENT CELL EXOSOMES AND USES THEREOF
To provide compositions of placenta-derived adherent cell exosomes and methods of making and using the same.SOLUTION: A composition comprises exosomes derived from human placenta-derived adherent cells, where the exosomes are CD9+, CD10+, CD13+, CD29+, CD44+, CD49b+, CD49c+, CD55+, CD59+, CD63+, CD7...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; jpn |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To provide compositions of placenta-derived adherent cell exosomes and methods of making and using the same.SOLUTION: A composition comprises exosomes derived from human placenta-derived adherent cells, where the exosomes are CD9+, CD10+, CD13+, CD29+, CD44+, CD49b+, CD49c+, CD55+, CD59+, CD63+, CD73+, CD81+, CD82+, CD90+, CD98+, CD105+, CD141+, CD142+, CD151+, CD164+, CD295+, or CD200+.SELECTED DRAWING: Figure 1
【課題】胎盤由来の接着細胞エクソソームの組成物、ならびにこれを作製及び使用する方法を提供する。【解決手段】ヒト胎盤由来の接着細胞由来のエクソソームを含む組成物であって、前記エクソソームは、CD9+、CD10+、CD13+、CD29+、CD44+、CD49b+、CD49c+、CD55+、CD59+、CD63+、CD73+、CD81+、CD82+、CD90+、CD98+、CD105+、CD141+、CD142+、CD151+、CD164+、CD295+、またはCD200+である。【選択図】図1 |
---|